Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO.
Details
State: Public
Version: Final published version
Serval ID
serval:BIB_2F7530178F85
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO.
Journal
Swiss medical weekly
ISSN
1424-3997 (Electronic)
ISSN-L
0036-7672
Publication state
Published
Issued date
05/09/2017
Peer-reviewed
Oui
Volume
147
Pages
w14484
Language
english
Notes
Publication types: Journal Article
Publication Status: epublish
Publication Status: epublish
Abstract
Antiosteoporotic drugs are recommended in patients with fragility fractures and in patients considered to be at high fracture risk on the basis of clinical risk factors and/or low bone mineral density. As first-line treatment most patients are started with an antiresorptive treatment, i.e. drugs that inhibit osteoclast development and/or function (bisphosphonates, denosumab, oestrogens or selective oestrogen receptor modulators). In the balance between benefits and risks of antiresorptive treatment, uncertainties remain regarding the optimal treatment duration and the management of patients after drug discontinuation. Based on the available evidence, this position statement will focus on the long-term management of osteoporosis therapy, formulating decision criteria for clinical practice.
Keywords
Antibodies, Monoclonal, Humanized/therapeutic use, Bone Density Conservation Agents/therapeutic use, Denosumab/therapeutic use, Diphosphonates/therapeutic use, Evidence-Based Practice, Female, Humans, Osteoporosis/drug therapy, Osteoporotic Fractures/prevention & control, Risk Factors, Time Factors
Pubmed
Web of science
Open Access
Yes
Create date
28/12/2017 16:15
Last modification date
03/02/2020 16:19